Quick search
Advanced search in
Field to searchTerm
Add rule
Download Results
841 research outcomes, page 1 of 85
  • publication . Article . 2016
    Open Access English
    Authors:
    Zh. D. Kobalava;
    Publisher: Stolichnaya Izdatelskaya Kompaniya

    <p>ESC Guidelines for the diagnosis and treatment of heart failure: what is new?</p>

    Add to ORCID
  • publication . Article . 2016
    Open Access English
    Authors:
    Y. A. Vasyuk; E. Y. Shupenina; E. N. Yuschuk; M. K. Serova;
    Persistent Identifiers
    Publisher: Stolichnaya Izdatelskaya Kompaniya

    Data about heart rate variability analysis in healthy people and patients with chronic heart failure are reviewed. Prognostic value of time-domain and spectral measures is mentioned. Influence of standard therapy on heart rate variability is described.

    Add to ORCID
  • publication . Article . 2016
    Open Access English
    Authors:
    N. V. Perova; Sokolov Ei; G. N. Shchukina; V. A. Metelskaya;
    Persistent Identifiers
    Publisher: Stolichnaya Izdatelskaya Kompaniya

    Current views on the efficacy criteria of hyperlipidaemia treatment with statins are considered. Requirements for generics of one of the widely used statin, simvastatin, are discussed. Data of several studies of Simvastol (generic simvastatin) and results of its use for...

    Add to ORCID
  • publication . Article . 2016
    Open Access English
    Authors:
    Array B. Sumarokov;
    Persistent Identifiers
    Publisher: Stolichnaya Izdatelskaya Kompaniya

    Antiplatelet agents are a necessary component of modern therapy of atherosclerosis. The difficulties of the antiplatelet treatment lie in balance between the necessary therapeutic effect and the risk of excessive action, leads to the bleeding. The ability to monitor ant...

    Add to ORCID
  • publication . Article . 2016
    Open Access English
    Authors:
    N. A. Dmitrieva; S. N. Tolpygina;
    Publisher: Stolichnaya Izdatelskaya Kompaniya

    <p>Data of evidence based medicine which confirm efficacy of acetylsalicylic acid (ACA) in cardiologic practice are presented. The special attention is given to generic drugs of ACA. Their application has increased essentially recently. Some of generics are comparable w...

    Add to ORCID
  • publication . Article . 2015
    Open Access English
    Authors:
    D. V. Nebieridze; T. V. Kamyshova;
    Publisher: Stolichnaya Izdatelskaya Kompaniya

    <p>The role of selective I1 imidazoline receptor agonists and moxonidine in particular , in modern antihypertensive therapy is discussed. Moxonidine advantages, namely positive effects on insulin resistance, endothelial dysfunction, lipid profile, and plasma fibrinolyti...

    Add to ORCID
  • publication . Article . 2015
    Open Access English
    Authors:
    S. R. Gilyarevskiy; V. A. Orlov; I. M. Kuz'mina;
    Publisher: Stolichnaya Izdatelskaya Kompaniya

    <p>The problem of the "optimal pharmacotherapy" choice in patients with stable coronary artery disease is discussed. Expert’s opinions are presented concerning first-line antiischemic drugs and about current approaches to the choosing additional (adjuvant) antiischemic ...

    Add to ORCID
  • publication . Article . 2016
    Open Access English
    Authors:
    A. O. Shevchenko; O. P. Shevchenko;
    Persistent Identifiers
    Publisher: Stolichnaya Izdatelskaya Kompaniya

    Peculiarities of the mode of action and clinical use of fixed low-dose combination of lisinopril and hydrochlorothiazide are discussed. Reasonability of ACE inhibitor and thiazide diuretic combination is supported due to more effective blood pressure control, organoprot...

    Add to ORCID
  • publication . Article . 2016
    Open Access English
    Authors:
    A. G. Avtandilov; K. M. Dzeranova; A. A. Pukhaeva; E. D. Manizer;
    Persistent Identifiers
    Publisher: Stolichnaya Izdatelskaya Kompaniya

    Mitral valve prolapse (MVP) is a manifestation of the hereditary syndrome of differentiated or undifferentiated connective tissue dysplasia (CTD). Genetic defect of synthesis and/or degradation of extracellular matrix is the basis of the CTD. MVP is a frequent manifesta...

    Add to ORCID
  • publication . Article . 2015
    Open Access English
    Authors:
    S. N. Tolpygina; S. Yu. Martsevich; E. N. Khoseva; N. V. Kiseleva;
    Publisher: Stolichnaya Izdatelskaya Kompaniya

    <p>Acetylsalicylic acid (ASA) use in the primary and secondary prevention of cardiovascular diseases is focused. Mode of ASA disaggregation action is discussed. Data of randomized controlled trials on ASA efficacy and safety in primary and secondary prevention are prese...

    Add to ORCID
841 research outcomes, page 1 of 85